Hemochromatosis heterozygotes may constitute a radiation-sensitive subpopulation

Radiation Research

Volumn 153, Issue 6, 2000, Pages 844-847

  Stevens, Richard G ^a,b   Morris, James E ^a   Anderson, Larry E ^a  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; IRON; SCAVENGER;

BREAST CARCINOMA; CANCER RISK; DNA DAMAGE; HEMOCHROMATOSIS; HETEROZYGOTE; HUMAN; IRON OVERLOAD; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIATION INJURY; RADIOSENSITIVITY; REVIEW;

EID: 0034077891     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2000)153[0844:HHMCAR]2.0.CO;2     Document Type: Review

References (44)

1. B. Halliwell and J. M. C. Gutteridge, Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 186, 1-85 (1990).
2. P. A. Cerutti, Prooxidant states and tumor promotion. Science 227, 375-381 (1985).
3. H. J. H. Fenton, Oxidation of tartaric acid in the presence of iron. J. Chem. Soc. 65, 899-910 (1894).
4. R. G. Stevens, R. P. Beasley and B. S. Blumberg, Iron-binding proteins and risk of cancer in Taiwan. J. Natl. Cancer Inst. 76, 605-610 (1986).
5. R. G. Stevens, D. Y. Jones, M. S. Micozzi and P. R. Taylor, Body iron stores and the risk of cancer. N. Engl. J. Med. 319, 1047-1052 (1988).
6. J. D. Cook, Adaptation in iron metabolism. Am. J. Clin. Nutr. 51, 301-308 (1990).
7. C. Q. Edwards, L. M. Griffen, D. Goldgar, C. Drummond, M. Skolnick and J. P. Kushner, Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N. Engl. J. Med. 318, 1355-1362 (1988).
8. S. Toyokuni, Iron-induced carcinogenesis: The role of redox cycling. Free Radic. Biol. Med. 20, 553-566 (1996).
9. R. G. Stevens and D. R. Kalkwarf, Iron, radiation, and cancer. Environ. Health Perspect. 87, 291-300 (1990).
10. L. A. Loeb, E. A. James, A. M. Waltersdorph and S. J. Klebanoff, Mutagenesis by autoxidation of iron with isolated DNA. Proc. Natl. Acad. Sci. USA 85, 3918-3922 (1988).
11. J. A. Imlay and S. Linn, DNA damage and oxygen radical toxicity. Science 240, 1302-1309 (1988).
12. H. J. Thompson, K. Kennedy, M. Win and J. Juzefyk, Effect of dietary iron deficiency or excess on the induction of mammary carcinogenesis by l-methyl-l-nitrosourea. Carcinogenesis 12, 111-114 (1991).
13. P. Knekt, A. Reunanen, H. Takkunen, A. Aromaa, M. Heliovaara and T. Hakulinen, Body iron stores and risk of cancer. Int. J. Cancer 56, 379-382 (1994).
14. J. L. Wurzelmann, A. Silver, D. M. Schreinemachers, R. S. Sandler and R. B. Everson, Iron intake and the risk of colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 5, 503-507 (1996).
15. J. V. Selby and G. D. Friedman, Epidemiological evidence of an association of body iron stores and risk of cancer. Int. J. Cancer 41, 677-682 (1988).
16. L. J. Herrinton, G. D. Friedman, D. Baer and J. V. Selby, Transferrin saturation and risk of cancer. Am. J. Epidemiol. 142, 692-628 (1995).
17. J. M. Nelson and R. G. Stevens, Ferritin-iron increases killing of Chinese hamster ovary cells by x irradiation. Cell Prolif. 25, 579-585 (1992).
18. R. A. Floyd, Direct demonstration that ferrous iron complexes of di-and triphosphate nucleotides catalyze hydroxyl free radical formation from hydrogen peroxide. Arch. Biochem. Biophvs. 255, 263-270 (1983).
19. R. F. Whiting, L. Wei and H. F. Stitch, Chromosome-damaging activity of ferritin and its relation to chelation and reduction of iron. Cancer Res. 41, 1628-1636 (1981).
20. W. Burke, E. Thomson, M. J. Khoury, S. M. McDonnell, N. Press. P. C. Adams, J. C. Barton, E. Beutler, G. Brittenham and F. S. Collins. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. J. Am. Med. Assoc. 280, 172-178 (1998).
21. J. N. Feder, A. Gnirke, W. Thomas, Z. Tsuchihashi, D. A. Ruddy, A. Basava, F. Dormishian, R. Domingo, Jr.. M. C. Ellis and R. K. Wolff, A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13, 399-408 (1996).
22. E. Buetler, Targeted disruption of the HFE gene. Proc. Natl. Acad. Sci. USA 95, 2033-2034 (1998).
23. Editorial: Haemochromatosis . . . definite maybe! Nat. Genet. 13, 375-376 (1996).
24. R. A. Bradbear, C. Bain, V. Siskind, F. D. Schofield, S. Webb, E. M. Axelsen, J. W. Halliday, M. L. Bassett and L. W. Powell, Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver disease. J. Natl. Cancer Inst. 75, 81-84 (1985).
25. Z. J. Bulaj, L. M. Griffen, L. B. Jorde, C. Q. Edwards and J. P. Kushner, Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N. Engl. J. Med. 335, 1799-1805 (1996).
26. K. Houglum, G. A. Ramm, D. H. G. Crawford, J. L. Witztum, L. W. Powell and M. Chojkier, Excess iron induces hepatic oxidative stress and transforming growth factor β1 in genetic hemochromatosis. Hepatology 26, 605-610 (1997).
27. M. B. Kadiiska, M. J. Burkitt, Q-H. Xiang and R. P. Mason, Iron supplementation generates hydroxyl radical in vivo. J. Clin. Invest. 96, 1653-1657 (1995).
28. D. C. Malins and R. Haimanot, Major alterations in the nucleotide structure of DNA in cancer of the female breast. Cancer Res. 51, 5430-5432 (1991).
29. D. C. Malins, N. K. Polissar and S. J. Gunselman, Progression of human breast cancers to the metastatic state is linked to hydroxyl radical-induced DNA damage. Proc. Natl. Acad. Sci. USA 93, 2557-2563 (1996).
30. M. Singh, J. Lu, S. P. Briggs, J. N. McGinley, A. D. Haegele and H. J. Thompson, Effect of excess dietary iron on the promotion stage of 1-methyl-1-nitrosourea-induced mammary carcinogenesis: pathogenic characteristics and distribution of iron. Carcinogenesis 15, 1567-1570 (1994).
31. X. Y. Zhou, S. Tomatsu, R. E. Fleming, S. Parkkila, A. Waheed, J. Jiang, Y. Fei, E. M. Brunt, D. A. Ruddy and W. S. Sly, HFE gene knockout produces mouse model of hereditary hemochromalosis, Proc. Natl. Acad. Sci. USA 95, 2492-2497 (1998).
32. E. Ron, Ionizing radiation and cancer risk: evidence from epidemiology. Radiat. Res. 150 (Suppl.), S30-S41 (1998).
33. J. E. Repine, O. W. Pfenninger, D. W. Talmage, E. M. Berger and D. E. Pettijohn, Dimethyl sulfoxide prevents DNA nicking mediated by ionizing radiation or iron/hydrogen peroxide-generated hydroxyl radical. Proc. Natl. Acad. Sci. USA 78. 1001-1003 (1981).
34. L-J. Wu, G. Randers-Pehrson, A. Xu, C. A. Waldren, C. R. Geard, Z. Yu and T. K. Hei, Targeted cytoplasmic irradiation with alpha particles induces mutations in mammalian cells. Proc. Natl. Acad. Sci. USA 96, 4959-4964 (1999).
35. M. C. Joiner, P. Lambin, E. P Malaise, T. Robson, J. E. Arrand, K. A. Skov and B. Marples, Hypersensitivity to very-low single radiation dose: its relationship to the adaptive response and induced radioresistance. Mutat. Res. 358, 171-183 (1996).
36. L. E. Beckman, G. F. Van Landeghem, C. Sikstrom, A. Wahlin, B. Markevarn, G. Hallmans, P. Lenner, L. Athlin, R. Stenling and L. Beckman, Interaction between haemochromatosis and transferrin receptor genes in different neoplastic disorders. Carcinogenesis 20, 1231-1233 (1999).
37. M. C. Pike, D. V. Spicer, L. Dahmoush and M. F. Press, Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk, Epidemiol. Rev. 15, 17-35 (1993).
38. H. J. Sipe, S. J. Jordan, P M. Hanna and R. P. Mason, The metabolism of 17β-estradiol by lactoperoxidase: a possible source of oxidative stress in breast cancer. Carcinogenesis 15, 2637-2643 (1994).
39. S. Wyllie and J. G. Liehr, Release of iron from ferritin storage by redox cycling of stilbene and steroid estrogen metabolites. Arch. Biochem. Biophys. 346, 180-186 (1997).
40. M. Villalobos, D. Becerra, M. I. Nunez, M. T. Valenzuela, E. Sues, N. Olea, V. Pedraza and J. M. Ruiz de Almodovar, Radiosensitivity of human breast cancer cell lines of different hormone responsiveness. Modulatory effects of estradiol. Int. J. Radiat. Biol. 70, 161-169 (1996).
41. G. H. Paulsen, T. Strickert, A. B. Marthinsen and S. Lundgren, Changes in radiation sensitivity and steroid receptor content induced by hormonal agents and ionizing radiation in breast cancer cells in vitro. Acta Oncol. 35, 1011-1019 (1996).
42. D. E. Wazer, M. Joyce, G. Solares and R. Schmidt-Ullrich, Proliferative inhibition of human breast carcinoma cells by high concentration estradiol does not alter radiosensitivity. Breast Cancer Res. Treat. 18, 141-148 (1991).
43. K. E. Brown and C. A. Knudsen, Oxidized heme proteins in an animal model of hemochromatosis. Free Radic. Biol. Med. 24, 239-244 (1998).
44. L. L. de Zwart, J. H. N. Meerman, J. N. M. Commandeur and N. P. E. Vermeulen, Biomarkers of free radical damage: applications in experimental animals and humans. Free Radic. biol. Med. 26, 202-226 (1999).